351 related articles for article (PubMed ID: 9348546)
21. Sex, social status, and CRF receptor densities in naked mole-rats.
Beery AK; Bicks L; Mooney SJ; Goodwin NL; Holmes MM
J Comp Neurol; 2016 Feb; 524(2):228-43. PubMed ID: 26100759
[TBL] [Abstract][Full Text] [Related]
22. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
23. Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.
Gottowik J; Goetschy V; Henriot S; Kitas E; Fluhman B; Clerc RG; Moreau JL; Monsma FJ; Kilpatrick GJ
Neuropharmacology; 1997 Oct; 36(10):1439-46. PubMed ID: 9423932
[TBL] [Abstract][Full Text] [Related]
24. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior.
Heinrichs SC; Lapsansky J; Lovenberg TW; De Souza EB; Chalmers DT
Regul Pept; 1997 Jul; 71(1):15-21. PubMed ID: 9299637
[TBL] [Abstract][Full Text] [Related]
25. Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Schoeffter P; Feuerbach D; Bobirnac I; Gazi L; Longato R
Fundam Clin Pharmacol; 1999; 13(4):484-9. PubMed ID: 10456290
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner.
Dermitzaki E; Tsatsanis C; Minas V; Chatzaki E; Charalampopoulos I; Venihaki M; Androulidaki A; Lambropoulou M; Spiess J; Michalodimitrakis E; Gravanis A; Margioris AN
Endocrinology; 2007 Apr; 148(4):1524-38. PubMed ID: 17194738
[TBL] [Abstract][Full Text] [Related]
27. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor.
Lewis K; Li C; Perrin MH; Blount A; Kunitake K; Donaldson C; Vaughan J; Reyes TM; Gulyas J; Fischer W; Bilezikjian L; Rivier J; Sawchenko PE; Vale WW
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7570-5. PubMed ID: 11416224
[TBL] [Abstract][Full Text] [Related]
28. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
29. Molecular cloning and functional expression of the mouse CRF2(a) receptor splice variant.
Dautzenberg FM; Higelin J; Wille S; Brauns O
Regul Pept; 2004 Sep; 121(1-3):89-97. PubMed ID: 15256278
[TBL] [Abstract][Full Text] [Related]
30. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
[TBL] [Abstract][Full Text] [Related]
31. Expression and characterisation of human and rat CRF2alpha receptors.
Suman-Chauhan N; Carnell P; Franks R; Webdale L; Gee NS; McNulty S; Rossant CJ; Van Leeuwen D; MacKenzie R; Hall MD
Eur J Pharmacol; 1999 Aug; 379(2-3):219-27. PubMed ID: 10497909
[TBL] [Abstract][Full Text] [Related]
32. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
[TBL] [Abstract][Full Text] [Related]
33. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain.
Korosi A; Veening JG; Kozicz T; Henckens M; Dederen J; Groenink L; van der Gugten J; Olivier B; Roubos EW
Brain Res; 2006 Feb; 1072(1):46-54. PubMed ID: 16423327
[TBL] [Abstract][Full Text] [Related]
34. Cortagine: behavioral and autonomic function of the selective CRF receptor subtype 1 agonist.
Farrokhi CB; Tovote P; Blanchard RJ; Blanchard DC; Litvin Y; Spiess J
CNS Drug Rev; 2007; 13(4):423-43. PubMed ID: 18078427
[TBL] [Abstract][Full Text] [Related]
35. Three-amino acid motifs of urocortin II and III determine their CRF receptor subtype selectivity.
Jahn O; Tezval H; van Werven L; Eckart K; Spiess J
Neuropharmacology; 2004 Aug; 47(2):233-42. PubMed ID: 15223302
[TBL] [Abstract][Full Text] [Related]
36. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
37. Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.
Tezval H; Jahn O; Todorovic C; Sasse A; Eckart K; Spiess J
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9468-73. PubMed ID: 15192151
[TBL] [Abstract][Full Text] [Related]
38. Corticotropin-releasing factor receptors and urocortins, links between the brain and the heart.
Yang LZ; Tovote P; Rayner M; Kockskämper J; Pieske B; Spiess J
Eur J Pharmacol; 2010 Apr; 632(1-3):1-6. PubMed ID: 20132811
[TBL] [Abstract][Full Text] [Related]
39. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
40. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
